Circulating vitamin D and colorectal adenoma in asymptomatic average-risk individuals who underwent first screening colonoscopy: A case-control study

Digestive Diseases and Sciences

Volumn 57, Issue 3, 2012, Pages 753-763

  Hong, Sung Noh ^a   Kim, Jeong Hwan ^a   Choe, Won Hyeok ^a   Lee, Sun Young ^a   Seol, Dong Choon ^a   Moon, Hee Won ^a   Hur, Mina ^a   Yun, Yeo Min ^a   Sung, In Kyung ^a   Park, Hyung Seok ^a   Shim, Chan Sup ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

25 hydroxyvitamin D3; Case control study; Colonoscopy; Colorectal adenoma; Vitamin D

Indexed keywords

CALCIFEDIOL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; ADENOMA; AGE DISTRIBUTION; BLOOD; COLON; COLORECTAL TUMOR; MASS SCREENING; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STATISTICS;

ADENOMA; AGE DISTRIBUTION; AGED; CALCIFEDIOL; CASE-CONTROL STUDIES; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84859497212     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1926-1     Document Type: Article

References (42)

1. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227-231. (Pubitemid 11238851)
2. Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev. 2005;14:2370-2376. (Pubitemid 41437839)
3. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673-1674. (Pubitemid 32568244)
4. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005;14:525-528. (Pubitemid 40270121)
5. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue eb1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 2000;60:2304-2312. (Pubitemid 30225198)
6. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-1086S. (Pubitemid 351549267)
7. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr. 2005;135:332-337. (Pubitemid 40194502)
8. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008; 88:500S-506S.
9. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:2958-2969.
10. Whelan RL, Horvath KD, Gleason NR, et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum. 1999;42:212-217. (Pubitemid 29085158)
11. Boutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study. Br J Cancer. 1996;74:145-151. (Pubitemid 26231993)
12. Peters U, McGlynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001;10:1267-1274. (Pubitemid 34027758)
13. Levine AJ, Harper JM, Ervin CM, et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 2001;39:35-41. (Pubitemid 32880946)
14. Boyapati SM, Bostick RM, McGlynn KA, et al. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor Bsmi polymorphism and nonsteroidal anti-inflammatory drug usě Cancer Epidemiol Biomarkers Prev. 2003;12:631-637. (Pubitemid 36899843)
15. Kampman E, Giovannucci E, van't Veer P, et al. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol. 1994;139:16-29. (Pubitemid 24048062)
16. Martinez ME, Marshall JR, Sampliner R, Wilkinson J, Alberts DS. Calcium, vitamin D, and risk of adenoma recurrence (United States). Cancer Causes Control. 2002;13:213-220. (Pubitemid 34438230)
17. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290:2959-2967. (Pubitemid 37505528)
18. Kesse E, Boutron-Ruault MC, Norat T, Riboli E, Clavel-Chapelon F. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the e3n-epic prospective study. Int J Cancer. 2005; 117:137-144. (Pubitemid 41262767)
19. Hartman TJ, Albert PS, Snyder K, et al. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr. 2005;135:252-259. (Pubitemid 40194487)
20. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martinez ME. Serum 25(oh)d levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol. 2007;103:752-756. (Pubitemid 46401330)
21. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol. 2007;165:1178-1186. (Pubitemid 47233720)
22. Platz EA, Hankinson SE, Hollis BW, et al. Plasma 1, 25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000;9: 1059-1065.
23. Peters U, Hayes RB, Chatterjee N, et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004;13: 546-552. (Pubitemid 38737889)
24. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003;95:1765-1771. (Pubitemid 38008899)
25. Fedirko V, Bostick RM, Goodman M, Flanders WD, Gross MD. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol. 2010;172:489-500.
26. Takahashi R, Mizoue T, Otake T, et al. Circulating vitamin D and colorectal adenomas in Japanese men. Cancer Sci. 2010;101: 1695-1700.
27. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer. 2007;109:510-517. (Pubitemid 46190958)
28. Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010;72:480-489.
29. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem. 2009;42:1549-1556.
30. Bushinsky DA, Monk RD. Electrolyte quintet: calcium. Lancet. 1998;352:306-311.
31. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381-1395. (Pubitemid 36936159)
32. Matusiak D, Benya RV. Cyp27a1 and cyp24 expression as a function of malignant transformation in the colon. J Histochem Cytochem. 2007;55:1257-1264. (Pubitemid 350156083)
33. Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res. 2011;71:413-423.
34. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-78.
35. Giovannucci E. Epidemiology of vitamin D and colorectal cancer: casual or causal link? J Steroid Biochem Mol Biol. 2010; 121:349-354.
36. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007;99:1120-1129. (Pubitemid 47241396)
37. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84:694-697. (Pubitemid 44715649)
38. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32:210-216. (Pubitemid 46223622)
39. Gorham ED, Garland CF, Garland FC, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol. 2005;97:179-194. (Pubitemid 41546228)
40. Connelly AE, Satia-Abouta J, Martin CF, et al. Vitamin C intake and apoptosis in normal rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2003;12:559-565. (Pubitemid 36713652)
41. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
42. Wactawski-Wende J, Kotchen JM, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-696. (Pubitemid 43247139)